OncoCyte Price to Book Ratio 2014-2023 | OCX
Historical price to book ratio values for OncoCyte (OCX) over the last 10 years. The current price to book ratio for OncoCyte as of May 01, 2024 is 1.03.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
OncoCyte Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2024-05-02 | 2.78 | 1.12 | |
2023-12-31 | 2.50 | $2.48 | 1.01 |
2023-09-30 | 3.12 | $4.55 | 0.69 |
2023-06-30 | 4.60 | $5.29 | 0.87 |
2023-03-31 | 7.09 | $6.36 | 1.11 |
2022-12-31 | 6.42 | $5.78 | 1.11 |
2022-09-30 | 14.60 | $12.96 | 1.13 |
2022-06-30 | 17.99 | $14.04 | 1.28 |
2022-03-31 | 29.80 | $12.35 | 2.41 |
2021-12-31 | 43.40 | $14.14 | 3.07 |
2021-09-30 | 71.20 | $21.56 | 3.30 |
2021-06-30 | 114.80 | $22.73 | 5.05 |
2021-03-31 | 103.80 | $23.98 | 4.33 |
2020-12-31 | 47.80 | $9.69 | 4.93 |
2020-09-30 | 27.80 | $10.30 | 2.70 |
2020-06-30 | 38.20 | $11.78 | 3.24 |
2020-03-31 | 49.00 | $11.72 | 4.18 |
2019-12-31 | 45.00 | $10.81 | 4.16 |
2019-09-30 | 42.00 | $11.29 | 3.72 |
2019-03-31 | 79.00 | $14.69 | 5.38 |
2018-12-31 | 27.60 | $1.68 | 16.39 |
2018-09-30 | 50.00 | $3.70 | 13.51 |
2018-06-30 | 51.00 | $3.47 | 14.68 |
2018-03-31 | 42.00 | $4.77 | 8.80 |
2017-12-31 | 93.00 | $2.80 | 33.22 |
2019-06-30 | 49.80 | $12.89 | 3.86 |
2017-09-30 | 151.00 | $5.12 | 29.47 |
2017-06-30 | 104.00 | $3.82 | 27.22 |
2017-03-31 | 119.00 | $5.97 | 19.92 |
2016-12-31 | 141.00 | $6.86 | 20.54 |
2016-09-30 | 100.80 | $8.84 | 11.40 |
2016-06-30 | 71.20 | $3.51 | 20.27 |
2016-03-31 | 92.20 | $5.43 | 16.99 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.021B | $0.002B |
OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $121.982B | 15.31 |
Cencora (COR) | United States | $45.721B | 17.82 |
ICON (ICLR) | Ireland | $24.881B | 23.49 |
DiDi Global (DIDIY) | China | $23.865B | 0.00 |
Avantor (AVTR) | United States | $16.588B | 24.42 |
Viatris (VTRS) | United States | $13.847B | 3.98 |
CochLear (CHEOY) | Australia | $13.505B | 0.00 |
Revvity (RVTY) | United States | $12.674B | 22.21 |
Medpace Holdings (MEDP) | United States | $12.327B | 40.56 |
Charles River Laboratories (CRL) | United States | $11.986B | 21.85 |
Natera (NTRA) | United States | $11.509B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.385B | 0.00 |
Solventum (SOLV) | United States | $11.239B | 0.00 |
Sonic Healthcare (SKHHY) | Australia | $8.205B | 0.00 |
HealthEquity (HQY) | United States | $6.843B | 51.12 |
Organon (OGN) | United States | $4.843B | 4.66 |
Bausch + Lomb (BLCO) | Canada | $4.828B | 19.35 |
Doximity (DOCS) | United States | $4.479B | 33.35 |
PACS (PACS) | United States | $3.736B | 0.00 |
Sotera Health (SHC) | United States | $3.190B | 15.65 |
Surgery Partners (SGRY) | United States | $3.131B | 28.98 |
Progyny (PGNY) | United States | $3.103B | 52.08 |
GoodRx Holdings (GDRX) | United States | $2.753B | 139.40 |
Life Times (LTH) | United States | $2.557B | 27.08 |
Premier (PINC) | United States | $2.523B | 9.24 |
AMN Healthcare Services Inc (AMN) | United States | $2.270B | 7.34 |
Teladoc Health (TDOC) | United States | $2.172B | 0.00 |
Agilon Health (AGL) | United States | $2.039B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.825B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.390B | 0.00 | |
Agiliti (AGTI) | United States | $1.374B | 22.44 |
NovoCure (NVCR) | Jersey | $1.371B | 0.00 |
Alignment Healthcare (ALHC) | United States | $0.995B | 0.00 |
Pediatrix Medical (MD) | United States | $0.757B | 7.83 |
Embecta (EMBC) | United States | $0.583B | 3.85 |
GeneDx Holdings (WGS) | United States | $0.545B | 0.00 |
InnovAge Holding (INNV) | United States | $0.527B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.525B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.517B | 0.00 |
Enhabit (EHAB) | United States | $0.511B | 46.27 |
LifeMD (LFMD) | United States | $0.476B | 0.00 |
CareDx (CDNA) | United States | $0.475B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.448B | 0.00 |
MultiPlan (MPLN) | United States | $0.414B | 0.00 |
Beauty Health (SKIN) | United States | $0.391B | 0.00 |
DocGo (DCGO) | United States | $0.353B | 56.50 |
Sera Prognostics (SERA) | United States | $0.338B | 0.00 |
ModivCare (MODV) | United States | $0.317B | 4.20 |
Sharecare (SHCR) | United States | $0.263B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.260B | 0.00 |
Biodesix (BDSX) | United States | $0.143B | 0.00 |
So-Young (SY) | China | $0.127B | 42.67 |
Oncology Institute (TOI) | United States | $0.083B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
NeueHealth (NEUE) | United States | $0.051B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.035B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
Nutex Health (NUTX) | United States | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
DermTech (DMTK) | United States | $0.021B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.007B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.006B | 0.00 |
OpGen (OPGN) | United States | $0.005B | 0.00 |
Assure Holdings (IONM) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |